{"url_path":"/fda/drug/recalls/D-0583-2026","section_key":"summary","section_title":"DRUG Recall: Breckenridge Pharmaceutical, Inc. — Duloxetine Delayed-Release Capsules, USP, 60mg, packaged in a) 90 Capsules (NDC 51991-748-90); b) 1000 Capsules (51991-748-10), Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-06-04","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0583-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Breckenridge Pharmaceutical, Inc."},"word_count":119,"has_tables":false,"body_markdown":null}